Winton Group’s Contineum Therapeutics CTNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-39,738
Closed -$582K 810
2024
Q4
$582K Buy
39,738
+28,602
+257% +$419K 0.04% 442
2024
Q3
$213K Buy
+11,136
New +$213K 0.01% 564